| Title : Nonomuraea sp. ATCC 55076 harbours the largest actinomycete chromosome to date and the kistamicin biosynthetic gene cluster - Nazari_2017_Medchemcomm_8_780 |
| Author(s) : Nazari B , Forneris CC , Gibson MI , Moon K , Schramma KR , Seyedsayamdost MR |
| Ref : Medchemcomm , 8 :780 , 2017 |
|
Abstract :
Glycopeptide antibiotics (GPAs) have served as potent clinical drugs and as an inspiration to chemists in various disciplines. Among known GPAs, complestatin, chloropeptin, and kistamicin are unique in that they contain an unusual indole-phenol crosslink. The mechanism of formation of this linkage is unknown, and to date, the biosynthetic gene cluster of only one GPA with an indole-phenol crosslink, that of complestatin, has been identified. Here, we report the genome sequence of the kistamicin producer Nonomuraea sp. ATCC 55076. We find that this strain harbours the largest actinobacterial chromosome to date, consisting of a single linear chromosome of approximately 13.1 Mbp. AntiSMASH analysis shows that approximately 32 biosynthetic gene clusters and approximately 10% of the genome are devoted to production of secondary metabolites, which include 1,6-dihydroxyphenazine and nomuricin, a new anthraquinone-type pentacyclic compound that we report herein. The kistamicin gene cluster (kis) was identified bioinformatically. A unique feature of kis is that it contains two cytochrome P450 enzymes, which likely catalyze three crosslinking reactions. These findings set the stage for examining the biosynthesis of kistamicin and its unusual indole-phenol crosslink in the future. |
| PubMedSearch : Nazari_2017_Medchemcomm_8_780 |
| PubMedID: 28626548 |
| Gene_locus related to this paper: 9actn-a0a1v0a4w1 , 9actn-a0a1v0ahf7 , 9actn-a0a1v0aiz8 |
| Gene_locus | 9actn-a0a1v0a4w1 9actn-a0a1v0ahf7 9actn-a0a1v0aiz8 |
Nazari B, Forneris CC, Gibson MI, Moon K, Schramma KR, Seyedsayamdost MR (2017)
Nonomuraea sp. ATCC 55076 harbours the largest actinomycete chromosome to date and the kistamicin biosynthetic gene cluster
Medchemcomm
8 :780
Nazari B, Forneris CC, Gibson MI, Moon K, Schramma KR, Seyedsayamdost MR (2017)
Medchemcomm
8 :780